GLP-1 Novo Nordisk’s Wegovy pill recommended for EU Approval The European Medicines Agency has recommended extending the marketing authorisation for Wegovy to include a once-daily pill
Obesity EU health chief warns obesity is a growing threat to Europe’s healthcare systems Rising obesity rates pose growing challenge to sustainability of Europe's healthcare system
Inside EU Health Inside EU Health: Antimicrobial risk on the rise to children with unmet medical needs Inside EU Health: Antimicrobial risk on the rise to children with unmet medical needs
Obesity Obesity Response Index highlights gaps in tackling obesity Economist Impact research reveals that most nations fall short in turning obesity policy into action, despite the growing problem
